BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34274203)

  • 1. How to predict para-aortic node involvement in advanced cervical cancer? Development of a predictive score. A FRANCOGYN study.
    Nguyen-Xuan HT; Benoit L; Dabi Y; Touboul C; Raimond E; Ballester M; Bendifallah S; Collinet P; Kerbage Y; Ouldamer L; Bricou A; Lavoue V; Carcopino X; Huchon C
    Eur J Surg Oncol; 2021 Nov; 47(11):2900-2906. PubMed ID: 34274203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.
    Shim SH; Kim DY; Lee SJ; Kim SN; Kang SB; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Jan; 144(1):40-45. PubMed ID: 27855989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of retroperitoneal lymph node status in locally advanced cervical cancer.
    Li W; Xiong L; Zhu Q; Lu H; Zhong M; Liang M; Jiang W; Wang Y; Cheng W
    BMC Cancer; 2021 May; 21(1):484. PubMed ID: 33933005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Added value of para-aortic surgical staging compared to
    De Cuypere M; Lovinfosse P; Goffin F; Gennigens C; Rovira R; Duch J; Fastrez M; Gebhart G; Squifflet JL; Luyckx M; Charaf G; Crener K; Buxant F; Bucella D; Jouret M; Hustinx R; Kridelka F
    Eur J Surg Oncol; 2020 May; 46(5):883-887. PubMed ID: 31784203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiotherapy.
    Kim DH; Kim WT; Bae JS; Ki YK; Park D; Suh DS; Kim KH; Lee JH; Lee JY; Jeon HS; Nam JH
    Int J Gynecol Cancer; 2016 Sep; 26(7):1274-80. PubMed ID: 27465890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer.
    Martinez A; Voglimacci M; Lusque A; Ducassou A; Gladieff L; Dupuis N; Angeles MA; Martinez C; Tanguy Le Gac Y; Chantalat E; Hitzel A; Courbon F; Ferron G; Gabiache E
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1252-1260. PubMed ID: 31915897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariate analysis of para-aortic lymph node recurrence after definitive radiotherapy for stage IB-IVA squamous cell carcinoma of uterine cervix.
    Huang EY; Wang CJ; Chen HC; Fang FM; Huang YJ; Wang CY; Hsu HC
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):834-42. PubMed ID: 18439764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: A systematic review and meta-analysis.
    Thelissen AAB; Jürgenliemk-Schulz IM; van der Leij F; Peters M; Gerestein CG; Zweemer RP; van Rossum PSN
    Gynecol Oncol; 2022 Mar; 164(3):667-674. PubMed ID: 34969533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer.
    Yen TC; See LC; Lai CH; Tsai CS; Chao A; Hsueh S; Hong JH; Chang TC; Ng KK
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):493-501. PubMed ID: 17955238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentric development and evaluation of
    Lucia F; Bourbonne V; Pleyers C; Dupré PF; Miranda O; Visvikis D; Pradier O; Abgral R; Mervoyer A; Classe JM; Rousseau C; Vos W; Hermesse J; Gennigens C; De Cuypere M; Kridelka F; Schick U; Hatt M; Hustinx R; Lovinfosse P
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2514-2528. PubMed ID: 36892667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases.
    Chao A; Ho KC; Wang CC; Cheng HH; Lin G; Yen TC; Lai CH
    Gynecol Oncol; 2008 Aug; 110(2):172-8. PubMed ID: 18499238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY; Huang YJ; Chanchien CC; Lin H; Wang CJ; Sun LM; Tseng CW; Tsai CC; Ou YC; Fu HC; Chen HC; Hsu HC; Wang CY
    Radiat Oncol; 2012 Jan; 7():13. PubMed ID: 22289572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
    Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
    Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraperitoneal para-aortic lymph node evaluation for cervical cancer via pfannenstiel incision: technique and peri-operative outcomes.
    Moore KN; Gold MA; McMeekin DS; Walker JL; Rutledge T; Zorn KK
    Gynecol Oncol; 2008 Mar; 108(3):466-71. PubMed ID: 18191994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy.
    Niibe Y; Nakano T; Ohno T; Suzuki Y; Oka K; Tsujii H
    Int J Gynecol Cancer; 2003; 13(6):849-55. PubMed ID: 14675323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
    Leblanc E; Gauthier H; Querleu D; Ferron G; Zerdoud S; Morice P; Uzan C; Lumbroso S; Lecuru F; Bats AS; Ghazzar N; Bannier M; Houvenaeghel G; Brenot-Rossi I; Narducci F
    Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of pretreatment and after treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer.
    Yilmaz B; Dağ S; Ergul N; Çermik TF
    Nucl Med Commun; 2019 Mar; 40(3):219-227. PubMed ID: 30585896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False negative rate at
    Gouy S; Seebacher V; Chargari C; Terroir M; Grimaldi S; Ilenko A; Maulard A; Genestie C; Leary A; Pautier P; Morice P; Deandreis D
    BMC Cancer; 2021 Feb; 21(1):135. PubMed ID: 33549033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The indication and surgery scope for laparoscopic extraperitoneal lymphadenectomy in locally advanced cervical cancer].
    Zhong ML; Liang MR; Jiang W; Wang YN; Zeng Y; Zeng SY
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):303-308. PubMed ID: 31014057
    [No Abstract]   [Full Text] [Related]  

  • 20. Mapping patterns of para-aortic lymph node recurrence in cervical cancer: a retrospective cohort analysis.
    Bae BK; Park SH; Jeong SY; Chong GO; Kim MY; Kim JC
    Radiat Oncol; 2021 Jul; 16(1):128. PubMed ID: 34246296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.